Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP676793.RAOFRNJhg3OBctrnyA7AoampYADrdMWWnWYOZoPqzKd44130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP676793.RAOFRNJhg3OBctrnyA7AoampYADrdMWWnWYOZoPqzKd44130_assertion type Assertion NP676793.RAOFRNJhg3OBctrnyA7AoampYADrdMWWnWYOZoPqzKd44130_head.
- NP676793.RAOFRNJhg3OBctrnyA7AoampYADrdMWWnWYOZoPqzKd44130_assertion description "[GCKR-L446 carriers are protected against type 2 diabetes despite higher triglyceride levels and risk of dyslipidemia, which suggests a potential molecular mechanism by which these two components of the metabolic syndrome can be dissociated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP676793.RAOFRNJhg3OBctrnyA7AoampYADrdMWWnWYOZoPqzKd44130_provenance.
- NP676793.RAOFRNJhg3OBctrnyA7AoampYADrdMWWnWYOZoPqzKd44130_assertion evidence source_evidence_literature NP676793.RAOFRNJhg3OBctrnyA7AoampYADrdMWWnWYOZoPqzKd44130_provenance.
- NP676793.RAOFRNJhg3OBctrnyA7AoampYADrdMWWnWYOZoPqzKd44130_assertion SIO_000772 18556336 NP676793.RAOFRNJhg3OBctrnyA7AoampYADrdMWWnWYOZoPqzKd44130_provenance.
- NP676793.RAOFRNJhg3OBctrnyA7AoampYADrdMWWnWYOZoPqzKd44130_assertion wasDerivedFrom befree-2016 NP676793.RAOFRNJhg3OBctrnyA7AoampYADrdMWWnWYOZoPqzKd44130_provenance.
- NP676793.RAOFRNJhg3OBctrnyA7AoampYADrdMWWnWYOZoPqzKd44130_assertion wasGeneratedBy ECO_0000203 NP676793.RAOFRNJhg3OBctrnyA7AoampYADrdMWWnWYOZoPqzKd44130_provenance.